Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany

被引:77
作者
Malorny, B [1 ]
Schroeter, A [1 ]
Helmuth, R [1 ]
机构
[1] Fed Inst Hlth Protect Consumers & Vet Med, D-12277 Berlin, Germany
关键词
D O I
10.1128/AAC.43.9.2278
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 24,591 nonhuman salmonella strains isolated in Germany between 1986 and 1998 were examined for their resistance to nalidixic acid by an agar diffusion method. The rate of resistance (inhibition zone, less than or equal to 13 mm) ranged from 0.2% in 1986 to a peak of 14.8% in 1990. Between 1991 and 1998 the MICs for nalidixic acid-resistant strains ranged from more than 256 mu g/ml for nalidixic acid to between 0.25 and 128 mu g/ml for enrofloxacin. In the early 1990s a particularly high incidence of fluoroquinolone resistance (49.5%) was seen among isolates of Salmonella enterica serotype Typhimurium (Salmonella Typhimurium) definitive phage type 204c that mainly originated from cattle. Among isolates from poultry an increase in the incidence of nalidixlic acid resistance to a peak of 14.4% was observed in 1991. This peak was due to the presence of specific resistant serotypes, mainly serotypes Hadar, Saintpaul, Paratyphi B (D-tartrate positive; formerly serotype Java) and New-port. Such strains exhibited a decreased susceptibility to enrofloxacin (MIC, 1 mu g/ml). Among isolates from pigs the peak incidence of resistance was reached in 1993, with 7.5% of isolates resistant to nalidixic acid and enrofloxacin. The study demonstrates an increase in the incidence of strains that are resistant to nalidixic acid and that have decreased susceptibility to enrofloxacin after the licensing of enrofloxacin. In addition, the number of other serotypes that exhibited nalidixic acid resistance or reduced enrofloxacin susceptibility increased among the total number of isolates investigated between 1992 and 1998.
引用
收藏
页码:2278 / 2282
页数:5
相关论文
共 37 条
[1]   EFFICACY OF CIPROFLOXACIN IN ENTERIC FEVER - COMPARISON OF TREATMENT DURATION IN SENSITIVE AND MULTIDRUG-RESISTANT SALMONELLA [J].
ALAM, MN ;
HAQ, SA ;
DAS, KK ;
BARAL, PK ;
MAZID, MN ;
SIDDIQUE, RU ;
RAHMAN, KM ;
HASAN, Z ;
KHAN, MAS ;
DUTTA, P .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 53 (03) :306-311
[2]   BACTERIOPHAGE-TYPING DESIGNATIONS OF SALMONELLA-TYPHIMURIUM [J].
ANDERSON, ES ;
WARD, LR ;
DESAXE, MJ ;
DESA, JDH .
JOURNAL OF HYGIENE, 1977, 78 (02) :297-300
[3]   Characterisation of recently emerged multiple antibiotic-resistant Salmonella enterica serovar typhimurium DT104 and other multiresistant phage types from Danish pig herds [J].
Baggesen, DL ;
Aarestrup, FM .
VETERINARY RECORD, 1998, 143 (04) :95-97
[4]  
*DTSCH I NORM EV, 1990, METH DET SUSC PATH 8
[5]  
*DTSCH I NORM EV, 1989, METH DET SUSC PATH 3
[6]   QUINOLONE RESISTANCE IN CAMPYLOBACTER ISOLATED FROM MAN AND POULTRY FOLLOWING THE INTRODUCTION OF FLUOROQUINOLONES IN VETERINARY-MEDICINE [J].
ENDTZ, HP ;
RUIJS, GJ ;
VANKLINGEREN, B ;
JANSEN, WH ;
VANDERREYDEN, T ;
MOUTON, RP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :199-208
[7]   Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991-1994 [J].
Frost, JA ;
Kelleher, A ;
Rowe, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :85-91
[8]  
GENSBERG K, 1995, FEMS MICROBIOL LETT, V132, P57, DOI 10.1016/0378-1097(95)00287-F
[9]   MOLECULAR MARKER ANALYSIS OF SALMONELLA-TYPHIMURIUM FROM SURFACE WATERS, HUMANS, AND ANIMALS [J].
GRAEBER, I ;
MONTENEGRO, MA ;
BUNGE, C ;
BOETTCHER, U ;
TOBIAS, H ;
HEINEMEYER, EA ;
HELMUTH, R .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1995, 11 (03) :325-331
[10]   QUINOLONE RESISTANCE IN VETERINARY ISOLATES OF SALMONELLA [J].
GRIGGS, DJ ;
HALL, MC ;
JIN, YF ;
PIDDOCK, LJV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (06) :1173-1189